InvestorsHub Logo
Followers 12
Posts 973
Boards Moderated 0
Alias Born 08/27/2015

Re: None

Tuesday, 05/05/2020 9:47:39 PM

Tuesday, May 05, 2020 9:47:39 PM

Post# of 35961
If Medicnova is using mipsagargin, I would assume it must be licensed, and therefore fees rendered in cash payments and/or equity.

This recent news is a good sign for the company.

https://www.biospace.com/article/releases/medicinova-receives-notice-of-allowance-for-second-patent-covering-mn-166-ibudilast-for-the-treatment-of-glioblastoma/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RBSH News